When I was in high school, we were taught about “truth tables.” It is a mathematical table used in logic to tell whether a propositional expression is true for all legitimate input values. Watching pundits speak on TV is makes you wonder how they could ever have passed high school algebra.
The Can’t Lose Argument
Beware those who are never wrong. The “Can’t Lose Argument” goes something like this: A data point will be mentioned, and no matter what the net change in that data — up, down or neutral — it is somehow bad for markets.
Sometimes they matter, sometimes they don’t. Sometimes one key divergence that was extremely important ends up meaning exactly zero the next time around. A single divergence, in and of itself, has all of the reliable predictive power of a bowl of chicken bones spilled out across the table.
ITC Ltd chairman Y C Deveshwar believes rich Indian entrepreneurs investing in real estate in US are showing investment opportunities in India in poor light. (DNA)ITC 357.20 -2.05 (-0.57%)
If they build, will you buy? A quarterly survey, based on responses from developers and financial institutions such as private equity funds, and banking and non-banking financial companies, shows sentiments are upbeat. (LiveMint)
Maybe you can buy shares in AIL? Arvind Ltd has approved demerger and transfer of its real estate business to Arvind Infrastructure Ltd (AIL). The company also said that AIL will be separately listed on stock exchange. (TOI) ARVIND 230.30 -10.35 (-4.30%)
Because, when you run the math, only builders, banks gain when you take loan to invest in realty. (TOI)
Flipkart, Amazon and various other e-commerce players are now in the India Shining v2.0 phase. They should probably talk to the Indian infrastructure companies who participated in India Shining v1.0 first before rushing headlong into the same “300 million consumer class” story. (WSJ)
The finance ministry has said that the income of the Alternative Investment Funds will be taxed at the maximum rate of 30% (DC)
CCI issues show-cause notices to Sun Pharma and Ranbaxy and asks why the deal should be cleared as it will lead to market domination. (LiveMint) SUNPHARMA 790.00 -0.45 (-0.06%)RANBAXY 581.50 -4.55 (-0.78%)
Britain’s new inflation index-linked gilt maturing in 2058 was so heavily oversubscribed that it was priced at a negative real yield. This means investors are willing to pay a small fee to the government in return for being compensated for inflation. (FT)